JVM Co

JVM Co Net Tangible Assets

The Net Tangible Assets of JVM Co (054950.KQ) as of Nov 4, 2026 is 233.95 B KRW. In the previous year, Net Tangible Assets was 199.65 B KRW — a change of 17.18% (higher).

Net Tangible Assets

233.95 BKRW

YoY

17.18%

Last updated:

Net Tangible Assets of JVM Co is 2025 233.95 B KRW. Net Tangible Assets of JVM Co was 2024 199.65 B KRW. It decreases by 17.18% higher compared to the previous year.

The JVM Co Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
112.50 B KRW
Jan 1, 2019
116.71 B KRW
Jan 1, 2020
132.61 B KRW
Jan 1, 2021
138.90 B KRW
Jan 1, 2022
155.05 B KRW
Jan 1, 2023
176.92 B KRW
Jan 1, 2024
199.65 B KRW
Jan 1, 2025
233.95 B KRW
The JVM Co Net Tangible Assets history
YEARNet Tangible AssetsYoY
233.95 BKRW+17.18%
199.65 BKRW+12.85%
176.92 BKRW+14.10%
155.05 BKRW+11.63%
138.90 BKRW+4.75%
132.61 BKRW+13.62%
116.71 BKRW+3.74%
112.50 BKRW+5.50%
106.64 BKRW+14.05%
93.50 BKRW+9.16%
85.66 BKRW+7.33%
79.80 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Net Tangible Assets of JVM Co is 233.95 B KRW in 2025.

Net Tangible Assets of JVM Co changed from 199.65 B KRW to 233.95 B KRW, representing a 17.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets JVM Co since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's JVM Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JVM Co

All Key Metrics — JVM Co